正商实业2022年年报

2022 ANNUALREPORT年报 目录 TABLEOFCONTENTS 23 CorporateProfile公司简介CorporateInformation公司资料 7482 IndependentAuditor’sReport独立核数师报告ConsolidatedStatementofProfitorLoss综合损益账 6 Chairman’sMessage主席致词 83 ConsolidatedStatementofComprehensiveIncome综合全面收益账 11 HongKongandOverseasPropertyPortfolio香港及海外物业组合 84 ConsolidatedStatementofFinancialPosition综合财务状况报表 14 PropertyDevelopmentProjectSummaryinthePRC在中国物业发展之项目概要 8687 ConsolidatedStatementofChangesinEquity综合权益变动表ConsolidatedStatementofCashFlows 26 ManagementDiscussionandAnalysis管理层讨论及分析 89 综合现金流量表NotestoFinancialStatements 35 BoardofDirectorsandSeniorManagement董事会及高级管理层 187 财务报表附注FinancialSummary 40 ReportoftheDirectors董事会报告书 188 财务概要ParticularsofMajorInvestmentProperties 60 CorporateGovernanceReport企业管治报告 主要投资物业概要 PastPerformanceandForwardLookingStatements TheperformanceandtheresultsofoperationsofZensunEnterprisesLimited(the“Company”)anditssubsidiaries(collectively,the“Group”)assetoutinthisannualreportarehistoricalinnatureandpastperformanceisnotaguaranteeoffutureperformance.Thisannualreportmaycontainforward-lookingstatementsandopinions(includingstatements,figures,plans,imagesandotherinformation)thatinvolverisksanduncertainties.Actualresultsmayalsodiffermateriallyfromexpectationsdiscussedinsuchforward-lookingstatementsandopinions.NeithertheGroupnoranyofitsdirectors,employeesoragentsshallassumeanyobligationsorliabilitiesintheeventthatanyforward-lookingstatementsoropinionsdoesnotmaterialiseorturnsouttobeincorrect. 过往表现及前瞻性陈述 正商实业有限公司（“本公司”）及其附属公司（统称“本集团”）在本年报所载的业务表现及营运业绩仅属历史数据，过往表现并不保证日后表现。本年报或载有前瞻性陈述及意见（包括陈述、数字、计划、图像及其他资料）而当中涉及风险及不明朗因素。实际业务表现可能与前瞻性陈述及意见中论及的预期表现有重大差异。本集团、及其任何董事、雇员、代理均不承担倘因任何前瞻性陈述或意见不能实现或变得不正确而引致的任何责任。 IncaseofanyinconsistencybetweentheEnglishtextandtheChinesetranslationofthisannualreport,theEnglishtextshallprevail. 本年报之英文版本与中文版本如有歧义，概以英文版本为准。 2ZensunEnterprisesLimited正商实业有限公司 CORPORATEPROFILE ZhengzhouZensunLongshuishangjing 郑州正商珑水上境 公司简介 ZensunEnterprisesLimited(the“Company”)wasfoundedin1965andlistedontheMainboardofTheStockExchangeofHongKongLimited(“StockExchange”)since1972.TheCompanyhasbeenincludedasaconstituentfortheMSCIHongKongSmallCapIndexinMay2021andasaconstituentfortheHangSengCompositeIndexinMarch2022respectively.TheCompanyanditssubsidiaries(collectively,the“Group”)primarilyengagesinpropertydevelopment,propertyinvestment,projectmanagementandsaleservices,hoteloperationsandsecuritiestradingandinvestmentinHongKong,ThePeople’sRepublicofChina(the“PRC”)andoverseas. WiththechangeofcontrollingshareholderoftheCompanysinceJuly2015,theGrouphasbeenexpandingitsbusinessinthepropertydevelopmentsectorinthePRC.Frommid2015andupto2022,theGroupcompleted161landacquisitionsthroughtenders,publiclistingsforsaleauctionsandothermergerandacquisitionsinsupportofthelandreservesforpropertydevelopmentbusinessinHenanProvince,BeijingandHubeiProvince.Asat31December2022,theGrouphad41completedpropertyprojectsand/orsub-phasesand55on-goingcomplexpropertyprojectsonhandwith116landparcelsunderdevelopmentandplanningconstitutingtheGroup’slandreserveswithanaggregatesiteareaofapproximately4.62millionsquaremetres(“sq.m.”)andaggregateestimatedgrossfloorarea(“GFA”)ofapproximately9.87millionsq.m.inthePRC.Inreturn,thelandreserveswillbringtotheGroupanestimatedsaleable/leasableGFAunderdevelopmentofapproximately6.21millionsq.m.andestimatedGFAunderplanningofapproximately3.66millionsq.m.Aftertheambitiouslandacquisitionscompletedinrecentyears,theGroupbuiltupstronglandreservesfortheGroup’spropertydevelopmentbusinessinthePRCforthenextthreetofouryearswithastrongpresenceinHenanProvince.Intheforeseeablefuture,theCompanywillcontinuetoidentifynewpropertydevelopmentprojectsandbidforlanduserightsofselectivelandparcelsinthePRCwithfocusonHenanProvince,aswellasotherselectivefirstandsecondtiercitiesinthePRC.In2022,theGrouphasstartedtooperateanewhotel,namely,ZensunJianguoHotel,thefirstLOFTthemedspacearthotelinZhengzhouCity,thePRC.InJanuary2023,ZensunJianguoHotelwonthe“2022GreatPartnerAward”fromTrip.com. IntheUnitedStates(“USA”or“U.S.”),theGroupholdsapproximately5.7%equityinterestovertheNYSE-listedrealestateinvestmenttrust(“REIT”),GlobalMedicalREIT,Inc.(“GMR”)asof31December2022,andcontinuestoshareGMR’sgrowththroughreceiptofdividendincome,therebyachievinglong-termcapitalappreciationoftheGroup’sinvestment. TheCompanywillmakeuseoftheGroup’sfinancial,humanandtechnologicalresourcestoenhanceitsportfolio,assetbaseandbrandimageinthePRC,USAandoverseaswithanaimtocreatenewsustainablerevenuestreamsandenhanceitsshareholdervalue. 正商实业有限公司（“本公司”）于1965年成立，自1972年起于香港联合交易所有限公司（“联交所”）主板上市。本公司分别于2021年5月获纳入MSCI香港小型股指数成份股及于2022年3月获纳入恒生综合指数成份股。本公司及其附属公司（统称“本集团”）主要于香港、中华人民共和国（“中国”）及海外从事物业发展、物业投资、项目管理及销售服务、酒店营运以及证券买卖及投资。 随着2015年7月之本公司控股股东变更，本集团不断扩张于中国物业发展行业之业务。自2015年年中至2022年，本集团透过招标及挂牌出售之公开拍卖会及其他合并及收购事项完成161幅位于河南省、北京及湖北省之土地收购以支持房地产发展业务之土地储备。于2022年12月31日，本集团于中国拥有41个已落成之物业项目及╱或项目分期及55个现行发展及规划中综合物业项目（共116幅地块）。有关项目构成本集团之土地储备，总占地面积约为4.62百万平方米及估计总建筑面积（“建筑面积”）约为9.87百万平方米。土地储备为本集团提供发展中估计可出售╱租赁建筑面积约6.21百万平方米及规划中估计建筑面积约3.66百万平方米。自近这些年度积极完成土地收